- Iain Armstrong joins from IP law firm HGF
- Will bring over 20 years of technical and legal expertise
Leading intellectual property law firm Mathys & Squire has appointed Chartered and European Patent Attorney Iain Armstrong as a new Partner in the life sciences team.
& Squire has appointed Chartered and European Patent Attorney Iain Armstrong as a new Partner in the life sciences team.
Iain joins from intellectual property law firm HGF, and brings over 20 years of biotech IP expertise during which he has worked with some of the world’s most prestigious research organisations and institutions, including AstraZeneca, the University of Oxford, Cancer Research UK and Novartis.
Iain’s particular areas of expertise include:
- Personalised cell-based therapies and therapeutics, notably CAR-T cells & IPSCs
- Wound healing and regenerative medicine
Martin MacLean, Partner and head of the life sciences team at Mathys & Squire says, “I’m absolutely delighted to welcome Iain onboard; it’s a coup for Mathys & Squire to attract a senior attorney of Iain’s calibre. His energy and enthusiasm speak volumes and his track record is exemplary.”
“Iain’s appointment is a major step in furthering Mathys & Squire’s strategic development in the life and medical sciences sectors. His extensive biotech knowledge and legal experience will prove a significant long-term asset to the firm.”
“Iain’s arrival further strengthens our top tier life sciences practice. His expertise will be hugely beneficial to our clients in this ever-advancing sector.”
About Mathys & Squire
Founded in 1910, Mathys & Squire is one of the leading full-service intellectual property law firms in Europe, with over 110 years of experience in the protection and commercialisation of IP rights.
The firm has more than 60 qualified attorneys and offices in London, Paris, Munich, Luxembourg, Cambridge, Oxford, Manchester, Birmingham, Brighton and York as well as a team based in China.
Mathys & Squire is highly ranked in all leading legal and IP directories, including The Legal 500, Chambers UK, and a recommended firm in both IAM Patent 1000 and WTR1000.